NeurAxis Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-14.57	-14.63	-4.78	-3.03	-3.73
Depreciation & Amortization	0.08	0.07	0.06	0.06	0.06
Share-Based Compensation	0.24	0	0.03	0.05	0.05
Other Operating Activities	6.85	7.86	2.39	0.69	-0.52
Operating Cash Flow	-7.4	-6.69	-2.3	-2.23	-4.14
Capital Expenditures	-0.08	-0.07	-0.06	-0	-0.03
Investing Cash Flow	-0.08	-0.07	-0.06	-0	-0.03
Share Issuance / Repurchase	4.85	4.85	0	0	0
Debt Issued / Paid	2.91	2.09	3.16	0.15	-0.72
Other Financing Activities	-0.24	-0.34	-0.87	0.51	6.77
Financing Cash Flow	7.52	6.59	2.29	0.66	6.05
Net Cash Flow	0.04	-0.18	-0.07	-1.57	1.89
Free Cash Flow	-7.48	-6.77	-2.36	-2.24	-4.17
Free Cash Flow Margin	-325.09%	-275.03%	-87.87%	-82.16%	-191.13%
Free Cash Flow Per Share	-1.14	-2.08	-1.18	-1.14	-2.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).